[Non-invasive Home-Ventilation: Pathophysiology, Initiation and Follow up]

Area of Science:

• Respiratory Medicine
• Pulmonology
• Critical Care

Background:

• Hypercapnia, characterized by elevated CO2, commonly stems from Chronic Obstructive Pulmonary Disease (COPD).
• However, other conditions like neuromuscular disorders (e.g., ALS) and restrictive thoracic disorders also significantly contribute to hypercapnic respiratory failure.
• Early detection of hypercapnic ventilatory failure often occurs during nocturnal monitoring.

Purpose of the Study:

• To outline the principles and initial settings for Non-invasive Ventilation (NIV) therapy in managing stable hypercapnia.
• To describe methods for optimizing NIV settings to achieve successful CO2 reduction.

Main Methods:

• NIV therapy utilizes alternating positive airway pressures (IPAP and EPAP) to support ventilation and CO2 elimination.
• Initial NIV settings for stable hypercapnia include Pressure Support Ventilation mode, EPAP of 5 cmH2O, IPAP of 15 cmH2O, and a backup rate of 15/minute.

Main Results:

• The primary objective of NIV treatment is the effective reduction of CO2 levels.
• Ventilator adjustments, including increasing IPAP, backup respiratory rate, or employing assisted pressure-controlled ventilation (APCV), can enhance CO2 elimination.

Conclusions:

• NIV is a crucial treatment modality for hypercapnic respiratory failure beyond COPD.
• Titration of NIV settings is essential for achieving therapeutic goals of CO2 reduction.